Indication
Steatosis of liver
Steatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes. Read more about Steatosis of liver
1 drugs 1 manufacturers
Drugs that treat it
Common Steatosis of liver therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSteatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes.
It affects the hepatic system across diverse populations and is defined histologically when lipid droplets occupy at least 5% of hepatocytes, or radiologically by increased intrahepatic fat content.
Pathophysiologically, it stems from an imbalance between the hepatic uptake or de novo synthesis of fatty acids and their subsequent mitochondrial oxidation or export via very-low-density lipoproteins.
While often asymptomatic and reversible in its early stages, hepatic steatosis serves as the foundational hallmark for both metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease, carrying the potential to progress to steatohepatitis, fibrosis, and cirrhosis.
- nih.gov
Steatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes
- nih.gov
Steatosis of liver, also termed hepatic steatosis or fatty liver, is a clinicopathologic state characterized by the abnormal intracellular accumulation of lipids, primarily triglycerides, within the cytoplasm of hepatocytes Pathophysiologically, it stems from an imbalance between the hepatic uptake or de novo synthesis of fatty acids and their subsequent mitochondrial oxidation or export via very-low-density lipoproteins
- nih.gov
It affects the hepatic system across diverse populations and is defined histologically when lipid droplets occupy at least 5% of hepatocytes, or radiologically by increased intrahepatic fat content While often asymptomatic and reversible in its early stages, hepatic steatosis serves as the foundational hallmark for both metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease, carrying the potential to progress to steatohepatitis, fibrosis, and cirrhosis
- nih.gov
It affects the hepatic system across diverse populations and is defined histologically when lipid droplets occupy at least 5% of hepatocytes, or radiologically by increased intrahepatic fat content
- medlineplus.gov
While often asymptomatic and reversible in its early stages, hepatic steatosis serves as the foundational hallmark for both metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease, carrying the potential to progress to steatohepatitis, fibrosis, and cirrhosis
Personalize your experience
Follow Steatosis of liver and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.